Format
Sort by
Items per page

Send to

Choose Destination

Best matches for mycobacteria type 2 diabetes:

Search results

Items: 1 to 20 of 122

1.

Metformin associated inflammation levels regulation in type 2 diabetes mellitus-tuberculosis coinfection patients - A case report.

Novita BD, Soediono EI, Nugraha J.

Indian J Tuberc. 2018 Oct;65(4):345-349. doi: 10.1016/j.ijtb.2018.08.006. Epub 2018 Sep 11.

PMID:
30522623
2.

Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C.

Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009. Epub 2018 Oct 1. Review.

PMID:
30514497
3.

Anakinra Therapy for Non-cancer Inflammatory Diseases.

Cavalli G, Dinarello CA.

Front Pharmacol. 2018 Nov 6;9:1157. doi: 10.3389/fphar.2018.01157. eCollection 2018. Review.

4.

IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?

Ronacher K, Sinha R, Cestari M.

Front Immunol. 2018 Sep 25;9:2209. doi: 10.3389/fimmu.2018.02209. eCollection 2018. Review.

5.

Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization.

Kewcharoenwong C, Prabowo SA, Bancroft GJ, Fletcher HA, Lertmemongkolchai G.

Front Immunol. 2018 Sep 19;9:2109. doi: 10.3389/fimmu.2018.02109. eCollection 2018.

6.

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis.

Teskey G, Cao R, Islamoglu H, Medina A, Prasad C, Prasad R, Sathananthan A, Fraix M, Subbian S, Zhong L, Venketaraman V.

Front Immunol. 2018 Sep 12;9:2069. doi: 10.3389/fimmu.2018.02069. eCollection 2018.

7.

Twenty-one episodes of peritonitis in a continuous ambulatory peritoneal dialysis patient: What is the root cause?

Nzana VB, Rohit A, George D, Vijayan M, Mathew M, Sankaran S, Nagarajan P, Abraham G.

Indian J Med Microbiol. 2018 Apr-Jun;36(2):282-284. doi: 10.4103/ijmm.IJMM_18_225.

8.

A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.

Novita BD, Pranoto A, Wuryani, Soediono EI, Mertaniasih NM.

Indian J Tuberc. 2018 Jul;65(3):252-256. doi: 10.1016/j.ijtb.2017.05.008. Epub 2017 Jun 3.

PMID:
29933869
9.

Comparison of acid fast bacilli (AFB) smear for Mycobacterium tuberculosis on adult pulmonary tuberculosis (TB) patients with type 2 diabetes mellitus (DM) and without type 2 DM.

Fachri M, Hatta M, Abadi S, Santoso SS, Wikanningtyas TA, Syarifuddin A, Dwiyanti R, Noviyanthi RA.

Respir Med Case Rep. 2018 Feb 25;23:158-162. doi: 10.1016/j.rmcr.2018.02.008. eCollection 2018.

10.

Risk Factors for Multidrug-resistant Tuberculosis.

Rumende CM.

Acta Med Indones. 2018 Jan;50(1):1-2.

11.

Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.

Ma Y, Pang Y, Shu W, Liu YH, Ge QP, Du J, Li L, Gao WW.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1259-1263. doi: 10.1007/s10096-018-3242-6. Epub 2018 Apr 20.

PMID:
29679254
12.

Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.

Lopez-Lopez N, Martinez AGR, Garcia-Hernandez MH, Hernandez-Pando R, Castañeda-Delgado JE, Lugo-Villarino G, Cougoule C, Neyrolles O, Rivas-Santiago B, Valtierra-Alvarado MA, Rubio-Caceres M, Enciso-Moreno JA, Serrano CJ.

Mem Inst Oswaldo Cruz. 2018 Feb 19;113(4):e170326. doi: 10.1590/0074-02760170326.

13.

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection.

Islamoglu H, Cao R, Teskey G, Gyurjian K, Lucar S, Fraix MP, Sathananthan A, Chan JK, Venketaraman V.

J Clin Med. 2018 Mar 1;7(3). pii: E40. doi: 10.3390/jcm7030040.

14.

Late-onset postoperative Mycobacterium haemophilum endophthalmitis masquerading as inflammatory uveitis: a case report.

Pinitpuwadol W, Sarunket S, Boonsopon S, Tesavibul N, Choopong P.

BMC Infect Dis. 2018 Feb 7;18(1):70. doi: 10.1186/s12879-018-2985-0.

15.

Cutaneous Mycobacterium gordonae infection in an elderly diabetic returned traveller.

Al-Busaidi I, Wong D, Boggild AK.

J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax019.

PMID:
28931126
16.

Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity.

Herrera MT, Gonzalez Y, Hernández-Sánchez F, Fabián-San Miguel G, Torres M.

BMC Infect Dis. 2017 Sep 7;17(1):610. doi: 10.1186/s12879-017-2705-1.

17.

Glycerol-3-phosphate phosphatase/PGP: Role in intermediary metabolism and target for cardiometabolic diseases.

Possik E, Madiraju SRM, Prentki M.

Biochimie. 2017 Dec;143:18-28. doi: 10.1016/j.biochi.2017.08.001. Epub 2017 Aug 5. Review.

PMID:
28826615
18.

IL-6 and IL-18 cytokine gene variants of pulmonary tuberculosis patients with co-morbid diabetes mellitus and their household contacts in Hyderabad.

Ponnana M, Sivangala R, Joshi L, Valluri V, Gaddam S.

Gene. 2017 Sep 5;627:298-306. doi: 10.1016/j.gene.2017.06.046. Epub 2017 Jun 23.

PMID:
28652186
19.

Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.

Kumar NP, Moideen K, Dolla C, Kumaran P, Babu S.

PLoS One. 2017 May 30;12(5):e0178000. doi: 10.1371/journal.pone.0178000. eCollection 2017.

20.

Influence of diabetes mellitus on immunity to human tuberculosis.

Kumar Nathella P, Babu S.

Immunology. 2017 Sep;152(1):13-24. doi: 10.1111/imm.12762. Epub 2017 Jun 29. Review.

Supplemental Content

Loading ...
Support Center